Abstract:Schistosomiasis is a serious and neglected disease with a high prevalence in tropical and subtropical countries. The primary pathology of hepatic schistosomiasis caused by Schistosoma japonicum ( S . japonicum ) or Schistosoma mansoni ( S . mansoni ) infection is egg-induced granuloma and subsequent fibrosis in the liver. Activation of hepatic stellate cells (HSCs) is the central driver of liver fibrosis. Macrophages (Mφ), making up 30% of cells in hepatic granulomas, directly or indirectly regulate HSC activation by paracrine mechanisms, via secreting cytokines or chemokines. Currently, Mφ-derived extracellular vesicles (EVs) are broadly involved in cell communication with adjacent cell populations. However, whether Mφ-derived EVs could target neighboring HSCs to regulate their activation during schistosome infection remains largely unknown. Schistosome egg antigen (SEA) is considered to be the main pathogenic complex mixture involved in liver pathology. Here, we demonstrated that SEA induced Mφ to produce abundant extracellular vesicles, which directly activated HSCs by activating their autocrine TGF-β1 signaling. Mechanistically, EVs derived from SEA-stimulated Mφ contained increased miR-33, which were transferred into HSCs and subsequently upregulated autocrine TGF-β1 in HSCs through targeting and downregulating SOCS3 expression, thereby promoting HSC activation. Finally, we validated that EVs derived from SEA-stimulated Mφ utilized enclosed miR-33 to promote HSC activation and liver fibrosis in S . japonicum -infected mice. Overall, our study indicates that Mφ-derived EVs play important roles in the paracrine regulation of HSCs during the progression of hepatic schistosomiasis, representing a potential target for the prevention of liver fibrosis in hepatic schistosomiasis. Schistosomiasis is a neglected parasitic disease affecting over 250 million people in tropical and subtropical regions. Among the common pathogenic species, Schistosoma japonicum and Schistosoma mansoni mainly cause hepatic schistosomiasis, which is mainly attributed to liver-trapped schistosome eggs, leading to granulomatous inflammation and liver fibrosis. HSC activation is the central driver of liver fibrosis during hepatic schistosomiasis. Macrophages (Mφ) are tightly connected to HSC activity. Currently, much evidence supports the pivotal role of Mφ-derived extracellular vesicles (EVs). However, the potential involvement of Mφ-derived EVs in HSC communication and modulation in hepatic schistosomiasis remains largely unknown. In this study, the authors illustrate that S . japonicum infection utilizes Mφ-derived EVs to promote HSC activation and liver fibrosis. Briefly, schistosome egg antigen (SEA) induces Mφ to secrete abundant miR-33-enriched EVs, which are transferred to enhance autocrine TGF-β1 production by targeting SOCS3 in HSCs, thereby promoting HSC activation and liver fibrosis. These discoveries provide a previously unrecognized Mφ-EVs-based therapeutic target regarding HSC activation, which can be manipulated to prevent liver fibrosis during hepatic schistosomiasis.

Endothelin receptors promote schistosomiasis-induced hepatic fibrosis via splenic B cells

Schistosome egg antigen stimulates the secretion of miR-33-carrying extracellular vesicles from macrophages to promote hepatic stellate cell activation and liver fibrosis in schistosomiasis

Sja-let-7 suppresses the development of liver fibrosis via Schistosoma japonicum extracellular vesicles

Pathological Changes in Hepatic Sinusoidal Endothelial Cells in Schistosoma japonicum-Infected Mice

Autophagy in hepatic progenitor cells modulates exosomal miRNAs to inhibit liver fibrosis in schistosomiasis

Intrasplenic Transplantation of IL-18 Gene-Modified Hepatocytes: an Effective Approach to Reverse Hepatic Fibrosis in Schistosomiasis Through Induction of Dominant Th1 Response

Follicular helper T cells recruit eosinophils into host liver by producing CXCL12 during Schistosoma japonicum infection.

A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III

Hepatic schistosomiasis as a determining factor in the development of hepatic granulomas and liver fibrosis: a review of the current literature

Effect of hepatocyte damage in hepatic fibrogenesis of patients infected with Schistosoma japonicum

The egg ribonuclease SjCP1412 accelerates liver fibrosis caused by Schistosoma japonicum infection involving damage-associated molecular patterns (DAMPs)

Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis

miR-182-5p attenuates <italic>Schistosoma japonicum</italic>-induced hepatic fibrosis by targeting tristetraprolin

Induction of hepatic fibrosis in mice with schistosomiasis by extracellular microRNA-30 derived from Schistosoma japonicum eggs

Single-cell RNA sequencing to dissect the immunological network of liver fibrosis in Schistosoma japonicum-infected mice

Dysregulated Glucuronidation of Bilirubin Exacerbates Liver Inflammation and Fibrosis in Schistosomiasis Japonica through the NF-κB Signaling Pathway

Lipid Metabolism Regulate the Inflammatory Microenvironment in the Hepatic Fibrosis Induced by Schistosoma Japonicum Infection in China: A Genotype-Phenotype Association Study

Longitudinal Immune Profiling Highlights CD4+ T Cell Exhaustion Correlated with Liver Fibrosis in Schistosoma japonicum Infection

Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis

[Expression of Smad Proteins in the Process of Liver Fibrosis in Mice Infected with Schistosoma Japonicum].

Involvement of SIRT1 in amelioration of schistosomiasis-induced hepatic fibrosis by genistein